ESC Premium Access

Bone marrow and splenic metabolic activity by 18F-FDG PET/CT are associated with noncalcified coronary burden and lipid-rich necrotic core in psoriasis

Congress Session

About the speaker

Ms Nidhi Patel

National Institutes of Health, Bethesda (United States of America)
0 follower

178 more presentations in this session

The quest for GRACE 3.0: improving our beloved risk score with machine learning

Speaker: Doctor J. Sousa (Coimbra, PT)


Percutaneous coronary interventions in patients with left main coronary artery pseudobifurcation lesions: 5-years follow-up

Speaker: Associate Professor D. Maximkin (Moscow, RU)


Use of intima media thickness in the assessment of the development of preclinical atherosclerosis

Speaker: Associate Professor R. Najafov (Baku, AZ)


Long term outcomes of patients with chronic inflammatory diseases after percutaneous coronary intervention

Speaker: Doctor O. Kobo (Hadera, IL)


Feasibility, safety and long term outcomes of complex left main bifurcation treatment using the nano inverted t stenting: a multicentre registry

Speaker: Associate Professor G. Rigatelli (Rovigo, IT)


Access the full session

Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters

Speakers: Ms N. Patel, Doctor J. Sousa, Associate Professor D. Maximkin, Associate Professor R. Najafov, Doctor O. Kobo...

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Generation and phenotyping of a novel knock-in mouse model of desmoplakin dependent arrhythmogenic cardiomyopathy.

29 August 2021

ESC Premium Access

Neutrophil-to-lymphocyte ratio predicts cardiovascular events in patients with type 2 diabetes: post hoc analysis of SUSTAIN 6 and PIONEER 6

28 August 2021

ESC Premium Access

Association between renal function and clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry

27 August 2021

This platform is supported by

logo Novo Nordisk